Your browser is no longer supported. Please, upgrade your browser.
SPDR S&P Pharmaceuticals ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-5.27%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-4.48%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter6.07%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y16.73%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year17.62%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range30.30 - 56.32 Perf YTD-2.04%
Dividend0.25 P/FCF- EPS past 5Y- ROI- 52W High-9.45% Beta-
Dividend %0.49% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low68.32% ATR1.10
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)33.80 Volatility2.06% 1.66%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.88 Prev Close52.32
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume57.15K Price51.00
Recom- SMA20-6.67% SMA50-4.58% SMA2008.46% Volume107,388 Change-2.52%
Oct-14-20 09:01AM  
Aug-11-20 03:29PM  
Jun-04-20 01:00PM  
May-22-20 07:46AM  
Feb-07-20 11:05AM  
Jan-15-20 01:55PM  
Jan-13-20 01:31PM  
Jan-08-20 11:12AM  
Dec-27-19 02:19PM  
Dec-26-19 02:30PM  
Nov-08-19 08:00AM  
Nov-06-19 11:00AM  
Oct-30-19 10:43AM  
Oct-26-19 06:00AM  
Oct-15-19 12:21PM  
Oct-13-19 05:15PM  
Aug-27-19 04:11PM  
Aug-22-19 11:12AM  
Aug-07-19 10:59AM  
Jul-14-19 11:00AM  
Jul-09-19 05:39PM  
Jul-08-19 10:42AM  
Jul-05-19 04:22PM  
Jun-26-19 11:00AM  
Jun-25-19 06:01PM  
Jun-17-19 04:01PM  
Jun-10-19 07:51AM  
May-14-19 05:40PM  
May-13-19 02:59PM  
May-09-19 10:05AM  
May-02-19 02:28PM  
Apr-23-19 03:11PM  
Apr-22-19 08:00AM  
Apr-19-19 08:02AM  
Apr-09-19 02:14PM  
Apr-03-19 12:23PM  
Mar-01-19 08:00AM  
Feb-28-19 04:43PM  
Feb-15-19 02:16PM  
Feb-07-19 11:15AM  
Jan-29-19 07:29AM  
Jan-23-19 11:33AM  
Jan-06-19 09:32AM  
Dec-31-18 02:30PM  
Dec-21-18 12:55PM  
Dec-17-18 12:25PM  
Dec-14-18 09:55AM  
Nov-19-18 01:25PM  
Nov-12-18 03:46PM  
Nov-08-18 01:00PM  
Nov-07-18 04:28PM  
Oct-29-18 08:50AM  
Oct-25-18 10:39AM  
Oct-24-18 11:59AM  
Oct-22-18 03:30PM  
Oct-15-18 12:41PM  
Oct-12-18 06:00AM  
Sep-24-18 09:52AM  
Sep-06-18 04:56PM  
Aug-13-18 04:07PM  
Aug-02-18 07:29AM  
Jul-20-18 06:00AM  
Jul-19-18 10:14AM  
Jul-09-18 07:13AM  
Jul-03-18 03:19PM  
Jun-08-18 01:19PM  
Jun-04-18 11:01AM  
May-14-18 08:41AM  
Apr-02-18 12:12PM  
Mar-12-18 12:16PM  
Feb-01-18 07:29AM  
Jan-30-18 10:29AM  
Jan-25-18 11:10AM  
Jan-23-18 01:52PM  
Jan-22-18 09:01AM  
Jan-19-18 09:35AM  
Jan-18-18 10:47AM  
Jan-17-18 04:35PM  
Jan-11-18 12:58PM  
Jan-10-18 05:59PM  
Dec-28-17 10:31AM  
Nov-20-17 07:05AM  
Nov-06-17 12:00PM  
Oct-26-17 02:11PM  
Oct-24-17 06:06PM  
Oct-17-17 10:26AM  
Oct-16-17 12:33PM  
Sep-20-17 11:47AM  
Sep-19-17 05:09PM  
Sep-11-17 07:36AM  
Sep-04-17 10:36AM  
Aug-30-17 10:37AM  
Aug-23-17 09:08AM  
Aug-21-17 02:36PM  
Aug-11-17 08:42AM  
Aug-07-17 12:10PM  
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").